반응식
[ClH:1].Cl.[CH2:3]([S:10][C:11]1[CH:17]=[CH:16][C:14]([NH2:15])=[CH:13][C:12]=1/[CH:18]=[CH:19]/[C:20]1[C:26]2[CH:27]=[CH:28][CH:29]=[CH:30][C:25]=2[N:24]([CH3:31])[CH2:23][CH2:22][N:21]=1)[C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[C:32]([NH:35][CH2:36][C:37](O)=[O:38])(=[O:34])[CH3:33].ON1C2N=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>CN(C)C=O>[ClH:1].[ClH:1].[C:32]([NH:35][CH2:36][C:37]([NH:15][C:14]1[CH:16]=[CH:17][C:11]([S:10][CH2:3][C:4]2[CH:5]=[CH:6][CH:7]=[CH:8][CH:9]=2)=[C:12](/[CH:18]=[CH:19]/[C:20]2[C:26]3[CH:27]=[CH:28][CH:29]=[CH:30][C:25]=3[N:24]([CH3:31])[CH2:23][CH2:22][N:21]=2)[CH:13]=1)=[O:38])(=[O:34])[CH3:33]참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
To a mixture of 58 mg (0.114 mmol) of (E)-4-benzylthio-3-[2-(2,3-dihydro-1-methyl-1H-1,4-benzodiazepin-5-yl)vinyl]aniline dihydrochloride (prepared as described in Example 82), 20 mg (0.171 mmol) of N-acetylglycine and 1-hydroxy-7-azabenzotriazole in 5 ml of dimethylformamide was added 44 mg (0.228 mmol) of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride. The mixture was stirred for 4 hours. The solvent was removed and the residue was purified by column chromatography eluting with 5-20% methanol/dichloromethane and treated with 0.10 ml of 4M hydrogen chloride in dioxan. The solvent was evaporated and the residue was recrystallised from acetone/methanol/diethyl ether to give 10 mg of (E)-2-acetamido-4′-benzylthio-3′-[2-(2,3-dihydro-1-methyl-1H-1,4-benzodiazepin-5-yl)vinyl]acetanilide dihydrochloride as a yellow solid; MS: m/e 499 (M+).
후처리
- customThe solvent was removed
- customthe residue was purified by column chromatography
- washeluting with 5-20% methanol/dichloromethane
- additiontreated with 0.10 ml of 4M hydrogen chloride in dioxan
- customThe solvent was evaporated
- customthe residue was recrystallised from acetone/methanol/diethyl ether
출처 및 근거
- ORD 기록
- ord-0846c4213df5443fbb8ab065be09d321
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06703387B2
연결된 노트
불러오는 중…